Global virus filtration market will reach $6,275.3 million by 2026, growing by 12.26% annually over 2020-2026 owing to rapid growth of pharmaceutical and biotechnology industry, increasing investments in R&D, surging need for virus removal and clearance amid COVID-19 pandemic.
Highlighted with 84 tables and 78 figures, this 157-page report "Global Virus Filtration Market 2020-2026 by Product (Consumables, Instruments, Services), Application, End User, and Region: COVID-19 Impact and Growth Opportunity" is based on a holistic research of the entire global virus filtration market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2016-2019 and provides forecast from 2020 till 2026 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
- Market Structure
- Growth Drivers
- Restraints and Challenges
- Emerging Product Trends & Market Opportunities
- Porter's Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global virus filtration market in every aspect of the classification from perspectives of Product, Application, End User, and Region.

Based on Product, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2016-2026 included in each section.
Consumables
Instruments
- Filtration Systems
- Chromatography systems
Services

Based on Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2016-2026 included in each section.
Biological Applications
- Vaccines and Therapeutics
- Blood and Blood Products
- Cellular and Gene Therapy Products
- Tissue and Tissue Products
- Stem Cell Products
Medical Devices
Water Purification
Air Purification
Other Applications

Based on End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2016-2026 included in each section.
- Pharmaceutical and Biotechnology Companies
- Contract Research Organisations (CROs)
- Academic & Research Institutes
- Medical Device Companies
- Other End Users

Geographically, the following regions together with the listed national/local markets are fully investigated:
- APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
- Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
- North America (U.S., Canada, and Mexico)
- South America (Brazil, Columbia, Argentina, Rest of South America)
- MEA (Saudi Arabia, UAE, South Africa)
For each region and key country, detailed analysis and data for annual revenue ($ mn) are available for 2016-2026. The breakdown of all regional markets by country and split of key national markets by Product, Application, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in global virus filtration market are assayed quantitatively and qualitatively through GMD's Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
Asahi Kasei Medical Co., Ltd.
Charles River Laboratories International, Inc.
Clean Cells
General Electric Company
Lonza Group AG
Merck KGaA
MilliporeSigma
Pall Corporation
Sartorius AG
Thermo Fisher Scientific, Inc.
Wuxi Apptec
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)